Crimson Publishers Publish With Us Reprints e-Books Video articles

Abstract

Open Journal of Cardiology & Heart Diseases

Cardio Oncologist: A Prerequisite for Preventing Cardiac Damage in Cancer Therapy

  • Open or CloseMisbah Ul Haq M*1, Munaf Ur Razzak M1, Ahmed N1, Yousuf Younus M1 and Ahmed O2,3,4

    1Deccan School of Pharmacy, Affiliated to Osmania University, India

    2Rajiv Gandhi University of Health Sciences (RGUHS) - V.L College of Pharmacy, Pharmaceutical Chemistry, India

    3Pacific (PAHER) University, Pharmaceutical Chemistry, India

    4Acharya Nagarjuna University Centre for Distance Education, Human Resource Management, India

    *Corresponding author:Misbah Ul Haq M, Deccan School of Pharmacy, Affiliated to Osmania University, India

Submission: February 14, 2022;Published: April 26, 2022

DOI: 10.31031/OJCHD.2022.03.000570

ISSN: 2578-0204
Volume3 Issue4

Abstract

To strengthen our understanding of cardiac oncology, we studied the fundamentals of oncology, focusing on the cardiovascular system and its effects on cardiotoxicity. The success of basic research and the study of specific diseases make cancer patients one of the fastest-growing subgroups. Interestingly, cardiovascular disorders are the 2nd major cause of illness and death after malignant tumors in cancer patients. A unique approach to addressing the early detection, prevention and treatment of cardiotoxicity in cancer patients has been proposed, for cancer patients as multidisciplinary cardiovascular care. Cancer therapies have been linked to a number of cardiovascular adverse effects, including arrhythmias, hypertension, and ischemic heart disease. This article highlights current practice guidelines for cancerrelated therapy’s potentially serious cardiotoxicity, as well as the importance, role, and need for a cardiooncologist.

Keywords: Cardiotoxicity; Cardio-Oncology; Cardiovascular system disease; Cardio-oncologist; Cancer

Get access to the full text of this article